Pay in 4 interest-free payments of $6.74 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
10.2147/DMSO.S348025 Summary Keywords GLP-1 receptor agonists, acute pancreatitis, FAERS, pharmacovigilance, data mining Citation Guo H, Guo Q, Li Z and Wang Z (2024) Association between different GLP-1 receptor agonists and acute pancreatitis: case series and real-world pharmacovigilance analysis
Patients with severe kidney or liver disorders should consult their doctor before starting this treatment
By weeks 48, weight loss becomes more noticeable as the dose increases and the body adjusts
Serious Risks: Prescribing information for GLP-1 medications includes boxed warnings about: Adherence Factors: According to experts quoted in coverage of the FDA approval, real-world adherence may differ from clinical trial conditions
Farr et al
US$ 23.41
US$ 22.57
US$ 27.41
US$ 23.21
US$ 25.57
US$ 27.07
US$ 23.15
US$ 20.70
